FDA approves HPV test for primary cervical cancer

  • April 24, 2014

The FDA today approved the cobas HPV Test for women aged at least 25 years to be used alone to aid a health care professional assess the need to undergo additional diagnostic testing for cervical cancer.

Using a sample of cervical cells, the cobas HPV Test (Roche) detects DNA from 14 high-risk HPV types. The test specifically identifies HPV types 16 and 18 while simultaneously detecting 12 other types of high-risk HPVs.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More»
More»
More»
  • Health Care Update
  • ARNOLD AND PORTER SILO
  • Medicare lab payments
  • New law will modernize Medicare lab payments: What physicians need to know. Analysis from Arnold & Porter LLP.
More »
  • Financial Planning
  • RUDZINSKI COLUMN
  • Advice for physicians
  • Be aware of important 2014 IRA updates. Analysis by Certified Financial Planner Ken Rudzinski.
More »
HemOnc Today